A new perspective on proteinuria and drug therapy for diabetic kidney disease

R Zhang, Q Wang, Y Li, Q Li, X Zhou, X Chen… - Frontiers in …, 2024 - frontiersin.org
Diabetic kidney disease (DKD) is one of the leading causes of end-stage renal disease
worldwide and significantly increases the risk of premature death due to cardiovascular …

Efficacy and safety of Abelmoschus manihot capsule combined with ACEI/ARB on diabetic kidney disease: a systematic review and meta analysis

Y Tan, Z Zhang, P Zhou, Q Zhang, N Li… - Frontiers in …, 2024 - frontiersin.org
Background: Diabetic kidney disease (DKD) is one of the most serious microvascular
complications of diabetes, with the incidence rate increasing yearly, which is the leading …

[HTML][HTML] Myricetin induces M2 macrophage polarization to alleviate renal tubulointerstitial fibrosis in diabetic nephropathy via PI3K/Akt pathway

WL Xu, PP Zhou, X Yu, T Tian, JJ Bao… - World Journal of …, 2024 - ncbi.nlm.nih.gov
BACKGROUND Development of end-stage renal disease is predominantly attributed to
diabetic nephropathy (DN). Previous studies have indicated that myricetin possesses the …

Understanding Proteinuria in Patients with Diabetic Kidney Disease and Progress of Drug Therapy from a New Perspective

R Zhang, Q Wang, X Zhou, Q Li, Z Dong, X Chen - 2023 - preprints.org
Diabetic kidney disease (DKD) is one of the leading causes of end-stage renal disease
worldwide and significantly increases the risk of premature death due to cardiovascular …